Europe Bone Marrow Biopsy Market – Industry Trends and Forecast to 2030

Europe Bone Marrow Biopsy Market Analysis and Size

The rising prevalence of blood disorders such as leukaemia and aplastic anaemia in both developed and developing countries necessitates bone marrow biopsy treatment. According to a National Cancer Institute report an estimated 405,815 people in the United States were diagnosed with leukaemia. However, insufficient bone marrow biopsy infrastructure is expected to stymie developing-country markets in the coming years. Invasive procedures such as bone marrow aspiration and biopsy necessitate highly technical skills in order to collect samples suitable for diagnostic processing and analysis. Needle size and calibre are important considerations in the technique selected based on the patient's age, gender, and weight.

Data Bridge Market Research analyses that the bone marrow biopsy market which was USD 36.794 million in 2022, is expected to reach USD 59.09 million by 2030, at a CAGR of 6.1% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Bone Marrow Biopsy Market Scope and Segmentation  

Market Definition

A bone marrow biopsy can detect abnormalities like bone marrow cancer and blood disorders that can affect blood cells and bone marrow, like leukaemia and lymphoma. A large needle is used to extract a bone marrow sample and a small amount of bone during a bone marrow biopsy. A bone marrow biopsy is an invasive procedure that must be performed by qualified personnel. As a result, this procedure is extremely beneficial to the market and is expected to grow exponentially in the future. Bone marrow aspiration and biopsy are invasive procedures that necessitate a high level of technical skill to collect samples suitable for processing and analysis of the diagnosis. One of the technique's key factors is needle size and calibre, which are determined by the patient's age, gender, and body mass.

Europe Bone Marrow Biopsy Market Dynamics

Drivers

• Increasing Prevalence of Blood Disorders

One of the key drivers driving the growth of the bone marrow biopsy market is rising demand for bone marrow biopsy as the incidence of blood disorders rises. Research and clinical trial initiatives have helped boost the bone marrow biopsy market. The increasing prevalence of early detection of these disorders is driving the use of bone marrow biopsy for treatment. These are the factors which propel the market growth.

• Advances in Technology in Healthcare Sector

Technological advancements in biopsy techniques will drive market growth in the bone marrow biopsy market during the forecast period. For instance, single-use or disposable needles ensure sterility for all procedures while also assisting in the prevention of cross contamination. During the forecast period, this is expected to boost the market. Furthermore, among all biopsy techniques, shave and saucerization biopsies are among the quickest and easiest to perform, and they will have a positive impact on business growth during the forecast period.

Opportunities

• Increase in Diagnosis Rate of Early Detection

All other techniques pale in comparison to bone marrow biopsy, which aids in the early detection of diseased conditions. This early detection rate is driving the market high and is expected to see rapid growth during the forecast period.

Restraints/Challenges

• High cost of biopsy tests

The market is expanding rapidly and is expected to expand further during the forecast period. The high cost of the procedures may be the most significant impediment. People may be hesitant to use this method of diagnosis due to the high cost of bone marrow biopsies, which may limit the growth of the bone marrow industry in the future.

This bone marrow biopsy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone marrow biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Bone Marrow Biopsy Market

The COVID-19 outbreak has caused an unprecedented global public health crisis that has impacted virtually every business. Its long-term consequences are expected to impact industry growth during the forecast period. Our ongoing research is improving our research strategy to ensure that fundamental COVID-19 concerns and potential solutions are addressed. COVID-19 has had a positive impact on the patient population's lives. The market flourished during and after the pandemic because the coronavirus may damage blood marrow cells in patients with severe COVID-19. The majority of patients with mild COVID-19 had their abnormal levels return to normal during their hospital stay. Monocytes did not function properly in COVID-19 patients with more severe disease. As a result, the bone marrow biopsies are important in this regard.

Europe Bone Marrow Biopsy Market Scope

The bone marrow biopsy market is segmented on the basis of product type, procedure type, biopsy type, site, technique, age, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Needles
• Instruments
• Biopsy Gun
• Procedure Trays
• Others

Procedure Type

• Hip Biopsy
• Breastbone (Sternum) Biopsy
• Percutaneous Trephine Biopsy
• Tibia (Shin) Biopsy
• Others

Biopsy Type

• Core Needle Biopsy
• Vacuum-Assisted Biopsy (VAB)
• Fine Needle Aspiration Biopsy

Site

• Posterior Iliac Crest
• Anterior Iliac Crest
• Calcaneus
• Distal Tibia
• Proximal Tibia
• Proximal Humerus
• Others

Technique

• Flow Cytometry
• Fluorescence In Situ Hybridization (Fish)
• Polymerase Chain Reaction (PCR)
• Karyotype Test
• Other

Age

• Geriatric
• Adult
• Pediatric

Application

• Lymphoma Disease
• Leukemia, Polycythemia Vera
• Multiple Myeloma
• Thrombocythemia
• Myelofibrosis
• Aplastic Anemia
• Others

End User

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centres
• Academic and Research Organizations
• Others

Bone Marrow Biopsy Market Regional Analysis/Insights

The bone marrow biopsy market is analyzed and market size insights and trends are provided by country, product type, procedure type, biopsy type, site, technique, age, application, end user and distribution channel as referenced above.

The countries covered in the bone marrow biopsy market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is dominating the Europe bone marrow biopsy market with the prevalence of chronic disease specially cancer in the country.

he country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The bone marrow biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bone marrow biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bone marrow biopsy market. The data is available for historic period 2011-2021.

Competitive Landscape and Bone Marrow Biopsy Market Share Analysis

The bone marrow biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bone marrow biopsy market.

Some of the major players operating in the bone marrow biopsy market are:

• BD (U.S.)
• Medtronic (Ireland)
• ARGON MEDICAL (U.S.)
• Merit Medical Systems (U.S.)
• Cardinal Health (U.S.)
• Teleflex Incorporated (U.S.)
• Biomedical Srl (Italy)
• BPB MEDICA (Italy)
• Egemen International (Turkey)
• hiprove (China)
• MDL SRL (Italy)
• SOMATEX Medical Technologies GmbH (Germany)
• STERYLAB S.r.l. (Italy)
• Tsunami Medical (Italy)
• weLLgo Medical Products GmbH (Germany)
• Zamar Care (U.S.)

SKU-53898